Zheng H, Xue H, Jiang H
Front Cell Dev Biol. 2022; 10:1012179.
PMID: 36425530
PMC: 9679416.
DOI: 10.3389/fcell.2022.1012179.
Calvier L, Herz J, Hansmann G
JACC Basic Transl Sci. 2022; 7(2):164-180.
PMID: 35257044
PMC: 8897182.
DOI: 10.1016/j.jacbts.2021.09.011.
Principe C, Dionisio de Sousa I, Prazeres H, Soares P, Lima R
Pharmaceuticals (Basel). 2021; 14(9).
PMID: 34577535
PMC: 8469001.
DOI: 10.3390/ph14090836.
Dwivedi R, Pandey R, Chandra S, Mehrotra D
Oncol Rev. 2020; 14(2):472.
PMID: 32685111
PMC: 7365992.
DOI: 10.4081/oncol.2020.472.
Yang X, Shen D, Zhao S, Ren T, Gao Y, Shi S
Oncol Lett. 2019; 17(1):63-68.
PMID: 30655738
PMC: 6313139.
DOI: 10.3892/ol.2018.9581.
Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway.
Paul D, Bargale A, Rapole S, Shetty P, Santra M
Neoplasia. 2018; 21(1):30-40.
PMID: 30500680
PMC: 6262785.
DOI: 10.1016/j.neo.2018.10.009.
MAEL contributes to gastric cancer progression by promoting ILKAP degradation.
Zhang X, Ning Y, Xiao Y, Duan H, Qu G, Liu X
Oncotarget. 2018; 8(69):113331-113344.
PMID: 29371914
PMC: 5768331.
DOI: 10.18632/oncotarget.22970.
The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.
Zheng H, Zhao S, Song Y, Ding X
Oncotarget. 2017; 8(61):103449-103464.
PMID: 29262575
PMC: 5732741.
DOI: 10.18632/oncotarget.21968.
The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.
Ding X, Zhao S, Yang L, Zhao X, Zhao G, Zhao S
Oncotarget. 2017; 8(47):81953-81966.
PMID: 29137236
PMC: 5669862.
DOI: 10.18632/oncotarget.17918.
The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
Zhao S, Yang X, Shen D, Gao Y, Shi S, Wu J
Oncotarget. 2016; 7(34):54596-54615.
PMID: 27409347
PMC: 5342367.
DOI: 10.18632/oncotarget.10519.
ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou W, Shen D, Yang X, Zhao S, Liu Y, Sun H
Oncotarget. 2015; 6(23):19552-79.
PMID: 25980581
PMC: 4637305.
DOI: 10.18632/oncotarget.3735.
ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
Linzen U, Lilischkis R, Pandithage R, Schilling B, Ullius A, Luscher-Firzlaff J
PLoS One. 2015; 10(4):e0123736.
PMID: 25860957
PMC: 4393124.
DOI: 10.1371/journal.pone.0123736.
The MOZ histone acetyltransferase in epigenetic signaling and disease.
Carlson S, Glass K
J Cell Physiol. 2014; 229(11):1571-4.
PMID: 24633655
PMC: 4750494.
DOI: 10.1002/jcp.24617.
Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
Hosseini S, Horton S, Saldivar J, Miuma S, Stampfer M, Heerema N
Genes Chromosomes Cancer. 2013; 52(11):1017-29.
PMID: 23929738
PMC: 4293015.
DOI: 10.1002/gcc.22097.
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T
Oncogene. 2011; 31(35):3939-48.
PMID: 22139082
PMC: 3667348.
DOI: 10.1038/onc.2011.554.
Sds22/PP1 links epithelial integrity and tumor suppression via regulation of myosin II and JNK signaling.
Jiang Y, Scott K, Kwak S, Chen R, Mardon G
Oncogene. 2011; 30(29):3248-60.
PMID: 21399659
PMC: 3141090.
DOI: 10.1038/onc.2011.46.
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.
Chow L, Endersby R, Zhu X, Rankin S, Qu C, Zhang J
Cancer Cell. 2011; 19(3):305-16.
PMID: 21397855
PMC: 3060664.
DOI: 10.1016/j.ccr.2011.01.039.
Ectodomains of the LDL receptor-related proteins LRP1b and LRP4 have anchorage independent functions in vivo.
Dietrich M, van der Weyden L, Prosser H, Bradley A, Herz J, Adams D
PLoS One. 2010; 5(4):e9960.
PMID: 20383322
PMC: 2850915.
DOI: 10.1371/journal.pone.0009960.
Inhibitor of growth tumor suppressors in cancer progression.
Piche B, Li G
Cell Mol Life Sci. 2010; 67(12):1987-99.
PMID: 20195696
PMC: 11115670.
DOI: 10.1007/s00018-010-0312-z.
Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.
Li X, Nishida T, Noguchi A, Zheng Y, Takahashi H, Yang X
J Cancer Res Clin Oncol. 2010; 136(10):1573-83.
PMID: 20182888
DOI: 10.1007/s00432-010-0815-x.